Aim Bulletin

SkinBioTherapeutics names Anita Slater as interim CFO

By Iain Gilbert

Date: Monday 24 Aug 2026

(Sharecast News) - Life sciences business SkinBioTherapeutics has tapped Anita Slater to take over as interim chief financial officer for an initial six-month term.
SkinBio said Slater will start her duties with immediate effect to ensure an orderly handover with an interim finance team.

The AIM-listed firm stated Slater has...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page